Literature DB >> 21312371

High-density microcarrier cell cultures for influenza virus production.

A Bock1, J Schulze-Horsel, J Schwarzer, E Rapp, Y Genzel, U Reichl.   

Abstract

Influenza virus A/PR/8/34 virus propagation in adherent Madin-Darby canine kidney cells in high-density microcarrier cultures is described. To improve virus yields, perfusion and repeated fed-batch modes were applied using cell-specific feed rates. Cell densities up to 1.1 × 10(7) cells/mL were achieved. Cell-specific virus yields in high-density cultures were at similar levels compared with standard, low-density cultivations. In the average 2,400 and 3,300 virions per cell were obtained for two variants of the virus strain A/PR/8/34, PR8-National Institute for Biological Standards and Control (NIBSC) and PR8-Robert Koch Institute, respectively. Maximum virus titer (HA activity = 1,778 HAU/100 μL) for virus variant PR8-NIBSC was obtained for a cultivation infected before maximum cell concentration was reached.
Copyright © 2011 American Institute of Chemical Engineers (AIChE).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21312371     DOI: 10.1002/btpr.539

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  8 in total

1.  Overcoming nutrient limitations for cell-based production of influenza vaccine.

Authors:  Xu-Ping Liu; Ding Huang; Wen-Song Tan; Jian Luo; Ze Chen
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Serum-free microcarrier based production of replication deficient influenza vaccine candidate virus lacking NS1 using Vero cells.

Authors:  Allen Chen; Swan Li Poh; Christian Dietzsch; Elisabeth Roethl; Mylene L Yan; Say Kong Ng
Journal:  BMC Biotechnol       Date:  2011-08-11       Impact factor: 2.563

Review 3.  Bioreactors for high cell density and continuous multi-stage cultivations: options for process intensification in cell culture-based viral vaccine production.

Authors:  Felipe Tapia; Daniel Vázquez-Ramírez; Yvonne Genzel; Udo Reichl
Journal:  Appl Microbiol Biotechnol       Date:  2016-01-13       Impact factor: 4.813

4.  Cell Density Effects in Different Cell Culture Media and Their Impact on the Propagation of Foot-And-Mouth Disease Virus.

Authors:  Veronika Dill; Janike Ehret; Aline Zimmer; Martin Beer; Michael Eschbaumer
Journal:  Viruses       Date:  2019-06-04       Impact factor: 5.048

5.  Evaluation of novel disposable bioreactors on pandemic influenza virus production.

Authors:  Chia-Chun Lai; Tsai-Chuan Weng; Yu-Fen Tseng; Jen-Ron Chiang; Min-Shi Lee; Alan Yung-Chih Hu
Journal:  PLoS One       Date:  2019-08-12       Impact factor: 3.240

6.  Live attenuated influenza viruses produced in a suspension process with avian AGE1.CR.pIX cells.

Authors:  Verena Lohr; Yvonne Genzel; Ingo Jordan; Dietmar Katinger; Stefan Mahr; Volker Sandig; Udo Reichl
Journal:  BMC Biotechnol       Date:  2012-10-30       Impact factor: 2.563

7.  Serum-Free Suspension Culture of MDCK Cells for Production of Influenza H1N1 Vaccines.

Authors:  Ding Huang; Wen-Juan Peng; Qian Ye; Xu-Ping Liu; Liang Zhao; Li Fan; Kang Xia-Hou; Han-Jing Jia; Jian Luo; Lin-Ting Zhou; Bei-Bei Li; Shi-Lei Wang; Wen-Ting Xu; Ze Chen; Wen-Song Tan
Journal:  PLoS One       Date:  2015-11-05       Impact factor: 3.240

8.  Improved poliovirus D-antigen yields by application of different Vero cell cultivation methods.

Authors:  Yvonne E Thomassen; Olaf Rubingh; René H Wijffels; Leo A van der Pol; Wilfried A M Bakker
Journal:  Vaccine       Date:  2014-02-26       Impact factor: 3.641

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.